SCHEMBL19233290

SCHEMBL19233290

CC(C)(C=O)c1cccc(C(=O)Nc2ccc(F)c(Nc3ncccc3-c3ncnc4[nH]ccc34)c2F)c1

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDR P35968 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19233284 0.91 KDR (1.00) KDR
SCHEMBL29448795 0.91 KDR (1.00) KDR
SCHEMBL19233431 0.90 KDR (0.84) KDR
SCHEMBL19233296 0.89 KDR (1.00) KDR
SCHEMBL19233589 0.84 KDR (0.77) KDR
SCHEMBL19233588 0.84 KDR (0.89) KDR
SCHEMBL19233295 0.81 KDR (0.80) KDR
SCHEMBL19233299 0.80 KDR (1.00) KDR
SCHEMBL20577886 0.80 KDR (0.83) KDR
SCHEMBL29448702 0.79 KDR (1.00) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017135589-A9 PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF 삼진제약주식회사 2017-10-19 WO disclosed
WO-2017135589-A1 PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF 삼진제약주식회사 2017-08-10 WO disclosed